Skip to content

The verification study for improving the intestinal environment

The verification study for improving the intestinal environment: a randomized, double-blind, placebo-controlled, parallel-group trial - The verification study for improving the intestinal environment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000038362
Enrollment
40
Registered
2020-04-01
Start date
2019-10-23
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Japanese subjects

Interventions

Duration: 2 weeks Test food: Fermentation product of soy milk with lactic acid bacteria Duration: 2 weeks Test food: Lactic acid bacteria-free sour clotted soy milk made of soy milk and lactic acid

Sponsors

ORTHOMEDICO Inc.
Lead Sponsor
Medical Corporation Seishinkai, Takara Clinic
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Healthy Japanese adult subjects 2. Subjects who defecate three to five times per week 3. Subjects who are judged as eligible to participate in the study by the physician 4. Subjects whose actual bacterial count of Bifidobacterium is not 0 5. Subjects who have relatively few defecation frequencies in a week before screening (before consumption)

Exclusion criteria

Exclusion criteria: 1. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, or myocardial infarction 2. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3. Currently undergoing treatment for any of the following chronic disease: cardiac arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, irritable bowel syndrome (IBS), or any other chronic diseases 4. Subjects who daily take "Foods for Specified Health Uses", "Foods with Functional Claims", yogurt, lactic fermenting beverage, or other functional food/beverage. Particularly taking food/beverage effective in intestine regulating. 5. Subjects who are currently taking medications (including herbal medicines) and supplements 6. Subjects who are allergic to medicines and/or the test food related products 7. Subjects who are pregnant, breast-feeding, and planning to become pregnant 8. Subjects who have been enrolled in other clinical trials within the last three months before the agreement to participate in this trial or plan to enroll in another clinical trial during trial period 9. Subjects who are judged as ineligible to participate in the study by the physician

Design outcomes

Primary

MeasureTime frame
Defecation frequency per week

Secondary

MeasureTime frame
1. Numbers of defecation days per week 2. Amount of defecation per week 3. Shape of stool 4. The Japanese version of Constipation Assessment Scale MT version (CAS-MT) 5. Bristol Stool Scale 6. Occupancy rate of enteric bacteria 7. Actual bacterial count of Bifidobacterium 8. Fecal pH 9. Water content in feces 10. Organic acids in feces 11. Putrefactive products in feces 12. Bile acids in feces 13. Facial skin assessment

Countries

Japan

Contacts

Public ContactNaoko SUZUKI

ORTHOMEDICO Inc. R&D Department

nao@orthomedico.jp03-3818-0610

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026